Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date

3152 results found

2023 ∙ Jacobsen, H. Sitaras, I. Katzmarzyk, M. Cobos Jiménez, V. Naughton, R. Higdon, M. M. Deloria Knoll, M.

Systematic review and meta-analysis of the factors affecting waning of post-vaccination neutralizing antibody responses against SARS-CoV-2

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Georganta, I. Chasapi, D. Smith, C. J. Kopsidas, K. Tatham, A.

Systematic review exploring the clinical features of optic neuritis after SARS-CoV infection and vaccination

  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Anderson, Robert Kim, Sungwook Roberts, Nia Petrou, Stavros

Systematic review of economic evaluations of varicella vaccination programmes

  • Newborn
  • Children
  • Adolescents
  • Adults
  • Healthcare workers
  • Varicella
  • Economic aspects
Methodological quality (AMSTAR 2):
Not applicable
2023 ∙ Moa, A. Kunasekaran, M. Akhtar, Z. Costantino, V. MacIntyre, C. R.

Systematic review of influenza vaccine effectiveness against laboratory-confirmed influenza among older adults living in aged care facilities

  • Older adults
  • Influenza
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Jesudason, T. Rodarte, A. Tordrup, D. Carias, C. Chen, Y. H.

Systematic review of rotavirus vaccination cost-effectiveness in high income settings utilising dynamic transmission modelling techniques

  • Newborn
  • Children
  • Rotavirus
  • Economic aspects
Methodological quality (AMSTAR 2):
Not applicable
2023 ∙ López-Carriches, C. Santana-Torres, T. Bahram-Taheri, R. Leco-Berrocal, M. I.

Systematic review of the oral manifestations produced by the SARS-CoV-2 vaccine

  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Ghazy, R. M. Elrewany, E. Gebreal, A. ElMakhzangy, R. Fadl, N. Elbanna, E. H. Tolba, M. M. Hammad, E. M. Youssef, N. Abosheaishaa, H. Hamouda, E. E. M. Mehana, Z. E. E. Al Zomia, A. S. A. Alnami R.A Salma, E. A. S. Alqahtani, A. S. Alshehri, A. F. Hussein, M.

Systematic Review on the Efficacy, Effectiveness, Safety, and Immunogenicity of Monkeypox Vaccine

  • All age groups
  • Mpox
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Reyburn, Rita Tsatsaronis, Anthea von Mollendorf, Claire Mulholland, Kim Russell, Fiona M. Duke T, Graham H. Graham S. Gray A. Gwee A. von Mollendorf C. Mulholland K. Russell F. Hume-Nixon M. Kazi S. Kevat P. Neal E. Nguyen C. Quach A. Reyburn R. Ryan K. Walker P. Wilkes C. Chua P. Nisar Y. B. Simon J. Were W. A. R. I. Review group

Systematic review on the impact of the pneumococcal conjugate vaccine ten valent (PCV10) or thirteen valent (PCV13) on all-cause, radiologically confirmed and severe pneumonia hospitalisation rates and pneumonia mortality in children 0-9 years old

  • Newborn
  • Children
  • Adolescents
  • Pneumococcal disease
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2023 ∙ Garbin, AjÍ Chiba, E. K. Garbin, C. A. S. Chiba, F. Y. Moimaz, S. A. S. Saliba, T. A.

Systematic review: Impact of parental decision on paediatric COVID-19 vaccination

  • Parents/caregivers
  • COVID-19
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2023 ∙ Lam, J. N. Nehira, J. Phung, O. Deng, B.

Systematic Review: Safety and Efficacy of mRNA COVID-19 Vaccines in Pregnant Women

  • Pregnant women
  • COVID-19
  • Safety
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
Loading...